Comparative Study on the Efficacy of Intravitreal and Subconjunctival Simultaneous Injection of Conbercept Followed by Trabeculectomy Versus Intravitreal Injection of Conbercept Followed by Trabeculectomy Combined With 5-Fluorouracil (5-FU) in the Treatment of Neovascular Glaucoma (NVG).
- 1Department of Ophthalmology The 2nd Affiliated Hospital of Harbin Medical University Harbin China hrbmush.edu.cn.
- 2Department of Ophthalmology China Medical University the Fourth People's Hospital of Shenyang Shenyang China.
Abstract
Purpose
To compare the efficacy of trabeculectomy preceded by simultaneous intravitreal and subconjunctival conbercept administration with that of trabeculectomy combined with 5-fluorouracil (5-FU) following intravitreal conbercept injection in patients with neovascular glaucoma (NVG).Methods
In this comparative study, 120 patients with NVG were enrolled and allocated to two treatment groups. Regression of neovascularization of the iris (NVI) and neovascularization of the angle (NVA) following conbercept administration was assessed. Additional outcome measures included intraocular pressure (IOP), visual acuity, filtering bleb morphology, use of antiglaucoma medications, surgical success rate, and postoperative complications before and after trabeculectomy.Results
On day 1 after conbercept injection, the group receiving simultaneous intravitreal and subconjunctival conbercept demonstrated significantly greater regression of NVI (p = 0.001) and NVA (p = 0.003) than the comparator group. Across follow-up visits, significant reductions in IOP were observed within both groups (time effect: F = 352.42, p = 0.001). Improvement in visual acuity did not differ significantly between groups (p > 0.05). Significant between-group differences in bleb height were observed at 1, 3, and 6 months after trabeculectomy (p = 0.008, p = 0.001, and p = 0.001, respectively). No significant difference in bleb extent was detected at any postoperative timepoint (F = 2.546, p = 0.080). Bleb vascularity differed significantly between groups throughout follow-up (F = 3.297, p = 0.021). Rates of postoperative complications, antiglaucoma medication use before surgery and within 6 months after injection, and overall surgical success did not differ significantly between groups (all p > 0.05).Conclusion
In patients with NVG undergoing trabeculectomy, simultaneous intravitreal and subconjunctival administration of conbercept was associated with more rapid regression of anterior-segment neovascularization and more favorable postoperative bleb characteristics. However, no significant between-group differences were observed in 6-month IOP control or surgical success. The potential benefits of the combined administration strategy appear to be mainly related to early neovascular regression and bleb morphology, and their significance for long-term surgical outcomes remains to be determined.
Related
- Successful management of high-risk proliferative diabetic retinopathy during pregnancy with intravitreal faricimab
- Retinitis and Choroiditis After the Seventh Intravitreal Pegcetacoplan Injection
- Intravitreal Nilotinib Reduces Fibroblast Growth Factor-2 Levels in a Rat Model of Dispase-Induced Intraocular Inflammation
- Intravitreal Anti-vascular Endothelial Growth Factor Injection Practices Among Indonesian Vitreoretinal Specialists: Findings From a 2021 National Survey
- Effect of Intravitreal Anti-VEGF Injections on the Vitreomacular Interface in Treatment-Naïve Eyes With Central Retinal Vein Occlusion
BibTeX
@article{xing2026comparative,
title = {{Comparative Study on the Efficacy of Intravitreal and Subconjunctival Simultaneous Injection of Conbercept Followed by Trabeculectomy Versus Intravitreal Injection of Conbercept Followed by Trabeculectomy Combined With 5-Fluorouracil (5-FU) in the Treatment of Neovascular Glaucoma (NVG).}},
author = {Peiyu Xing and Wei Qu and Yong Zhang and Xiaojia Hu and Heman Xu and Bo Meng and Hao Shao and Shaowei Wang},
journal = {Journal of ophthalmology},
year = {2026},
month = oct,
doi = {10.1155/joph/6946973},
url = {https://europepmc.org/article/MED/42948490},
note = {CC BY},
}
RIS
TY - JOUR
TI - Comparative Study on the Efficacy of Intravitreal and Subconjunctival Simultaneous Injection of Conbercept Followed by Trabeculectomy Versus Intravitreal Injection of Conbercept Followed by Trabeculectomy Combined With 5-Fluorouracil (5-FU) in the Treatment of Neovascular Glaucoma (NVG).
AU - Peiyu Xing
AU - Wei Qu
AU - Yong Zhang
AU - Xiaojia Hu
AU - Heman Xu
AU - Bo Meng
AU - Hao Shao
AU - Shaowei Wang
PY - 2026
DA - 2026/10/27
JO - Journal of ophthalmology
DO - 10.1155/joph/6946973
UR - https://europepmc.org/article/MED/42948490
AB - Purpose To compare the efficacy of trabeculectomy preceded by simultaneous intravitreal and subconjunctival conbercept administration with that of trabeculectomy combined with 5-fluorouracil (5-FU) following intravitreal conbercept injection in patients with neovascular glaucoma (NVG).Methods In this comparative study, 120 patients with NVG were enrolled and allocated to two treatment groups. Regression of neovascularization of the iris (NVI) and neovascularization of the angle (NVA) following conbercept administration was assessed. Additional outcome measures included intraocular pressure (IOP), visual acuity, filtering bleb morphology, use of antiglaucoma medications, surgical success rate, and postoperative complications before and after trabeculectomy.Results On day 1 after conbercept injection, the group receiving simultaneous intravitreal and subconjunctival conbercept demonstrated significantly greater regression of NVI (p = 0.001) and NVA (p = 0.003) than the comparator group. Across follow-up visits, significant reductions in IOP were observed within both groups (time effect: F = 352.42, p = 0.001). Improvement in visual acuity did not differ significantly between groups (p > 0.05). Significant between-group differences in bleb height were observed at 1, 3, and 6 months after trabeculectomy (p = 0.008, p = 0.001, and p = 0.001, respectively). No significant difference in bleb extent was detected at any postoperative timepoint (F = 2.546, p = 0.080). Bleb vascularity differed significantly between groups throughout follow-up (F = 3.297, p = 0.021). Rates of postoperative complications, antiglaucoma medication use before surgery and within 6 months after injection, and overall surgical success did not differ significantly between groups (all p > 0.05).Conclusion In patients with NVG undergoing trabeculectomy, simultaneous intravitreal and subconjunctival administration of conbercept was associated with more rapid regression of anterior-segment neovascularization and more favorable postoperative bleb characteristics. However, no significant between-group differences were observed in 6-month IOP control or surgical success. The potential benefits of the combined administration strategy appear to be mainly related to early neovascular regression and bleb morphology, and their significance for long-term surgical outcomes remains to be determined.
SN - 2090-004X
SN - 2090-0058
ER -